STOCK TITAN
  1. Home
  2. Sec-filings
  3. MNKD
  4. [Form 4] Mannkind Corporation Insider Trading Activity

[Form 4] Mannkind Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock MNKD logo
Mannkind

NASDAQ:MNKD

MNKD Rankings

#2327 Ranked by Market Cap
N/A Ranked by Dividends

MNKD Latest News

Oct 7, 2025
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
Sep 29, 2025
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
Aug 27, 2025
MannKind to Present at Upcoming Investor Conferences
Aug 27, 2025
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
Aug 25, 2025
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

MNKD Latest SEC Filings

Oct 9, 2025
[Form 3] MANNKIND CORP Initial Statement of Beneficial Ownership
Oct 9, 2025
[8-K] MANNKIND CORP Reports Material Event
Sep 16, 2025
[144] MANNKIND CORP SEC Filing
Sep 17, 2025
[Form 4] MANNKIND CORP Insider Trading Activity
Sep 17, 2025
[Form 4] MANNKIND CORP Insider Trading Activity

MNKD Stock Data

1.58B
301.53M
1.66%
55.86%
5.18%
Biotechnology
Pharmaceutical Preparations
Link
United States
DANBURY